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Abstract. This article includes the results of experiments on a flock of chickens. 
Experiments have been conducted  in order to assess the comparative immunological efficacy 
of different vaccines strains used in immunization against infectious avian bronchitis.  
Now it is a tendency to develop large production of substances and biologically 
active products, preparations of microorganisms, premix, growth stimulators, which are used 
for increase body mass, immunity, the percentage of viability and physiological resistance of 
the body. As a biologically active product, immunocorrectors is the 10% hydro- alcoholic 
solution of propolis.  
The propolis is considered a true gift of nature because the propolis includes the most 
useful organic elements. Propolis samples from different geographic origins were investigated 
for their antibacterial (against Staphylococcus aureus and Escherichia coli), antifungal 
(against Candida albicans) and antiviral (against avian influenza virus) activities. 
In this study data are presented confirming reduced post-vaccination immunological 
efficacy in chickens vaccinated at one day old and immune stimulatory effect and when 
the vaccine is administered in combination with the 10% hydro- alcoholic solution of propolis 
recommended by the instruction. In both cases was administrated the vaccine Ma5+Clon30  
with drenching water and spray method. The better immunological effect was obtained on the 
group of chickens which were vaccinated with strains Ma5+Clon30 in combination with the 
10% hydro- alcoholic solution of propolis. 
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IBV is the type species of the genus Coronavirus in the family Coronaviridae, Order 
Nidovirales. It is a Group 3 member in the genus Coronavirus, based on genetic and antigenic 
characteristics. Its genome consists of a single-stranded positive RNA molecule (approx. 27.6 
kb) that encodes 4 structural proteins: the spike (S), membrane (M), small membrane (E) and 
nucleoprotein (N).  Many antigenic types of the causative agent, infectious bronchitis virus 
(IBV), exist; for example, the Massachusetts, D274, 793B and B1648 serotypes. The 
Massachusetts type was the first isolated in Europe in the 1940s. The D274 type was the most 
common in several western European countries in the early and mid-1980s. The 793/B type 
was first identified in UK in 1990/1991, but was retrospectively found to have been present in 
France since 1985. The 793/B type is currently the dominant type infecting broilers. The 
B1648 type was isolated in Belgium in 1984 and was recently shown to be still present in 
Italy. 
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More than 25 genotypes are distributed worldwide. IBV causes an acute highly 
contagious viral respiratory disease of chickens which is characterized by respiratory rales, 
coughing and sneezing. Some IBV strains replicate in the gastrointestinal tract, oviduct, and 
kidney, and due to their nephropathogenic properties they have the potential to cause severe 
losses with up to 44% mortality. In other cases, infection of the proventriculus leads to 75% to 
100% mortality in young birds. Most isolates of IBV replicate well in the developing chicken 
embryo following inoculation of the allantoic cavity, and high titers of virus can be isolated 
from the allantoic fluid Infectious bronchitis (IB) is a major problem in the chicken industry, 
where infection occurs as both respiratory and nephrosis forms and is probably endemic in all 
regions where poultry are reared intesively.  
The primary tissue of IBV infection is the respiratory tract, though some isolates 
replicate in the kidney and oviduct, resulting in nephritis and reduced egg production. 
Generally, infectious bronchitis (IB) has been controlled with serotype-specific vaccines, but 
outbreaks of IB still occur, because vaccines offer little cross-protection between serologically 
distinct viruses. A high mutation frequency and RNA recombination leads to the emergence 
of new viruses capable of causing disease in vaccinated chickens. Although many countries 
share some common antigenic types, IBV strains within a geographic region are unique and 
distinct. The identification of the circulating IBV field strains is extremely important for the 
selection of vaccine strains for the corresponding geographical region. 
Identification and antigenic characterization of infectious bronchitis virus (IBV) field 
strains often require one or more in vitro tests such as virus neutralization (VN), 
haemagglutination inhibition, monoclonal antibody reactivity and, more recently, analysis of 
sequences, commonly of the spike glycoprotein gene. As valuable as the findings of these 
assays are, however, the major goal is to establish the relationship of field strains to vaccine 
strains using cross-challenge studies in the chicken. Vaccines are the primary method of 
controlling IBV infections in commercial chickens. The concept of classifying strains 
according to their ‘‘protectotype’’ has been proposed. However, given the logistical 
limitations (facilities and costs) of performing cross-challenge tests in chickens, scientists 
must often rely on using in-vitro tests to establish the relationship of IBV field strains and 
vaccines.  
Classic methods for IBV diagnosis include serological tests for analysis of antibody 
titers against IBV and virus isolation in embryonated chicken eggs since IBV grows well in 
the developing chicken embryo. These methods are inherently slow and time consuming. 
Currently, detection and serotype analysis of IBV is performed by RT-PCR and restriction 
fragment length polymorphism analysis or by sequencing RT-PCR products of S1 gene. 
Vaccines based on Massachusetts strains such as H120 and H52 and other strains 
such as 4-91 (Nobilis IB 4-91) have been used for many years on poultry farms. 
The aim of the research was to determine the presence of post vaccine antibody titers 
to infectious bronchitis virus, immunological efficacy assessment after vaccination. 
 
MATERIAL AND METHODS 
 
The investigations include the material which was obtained on experimental 
investigations. The experiment was conducted at State Agrarian University from Republic of 
Moldova, Faculty of Veterinary Medicine at the Department Epizootology.  
The samples of blood serum were collected from chickens which were varied from one 
day to 40 days old. The samples of blood serum were examined at the 
Republican Veterinary Diagnostic Center where they were used in the serological test 
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(ELISA). Were used diagnostic kits produced by IDEXX laboratory, U.S. Absorption value 
was 650 nm. In order for the needed test to be correctly assessed, the difference between the 
positive and the negative control was no more than 0,075.  
ELISA immunoassay test is used for qualitative and quantitative detection of 
biological substances: antibodies and antigens. 
The 10% hydro- alcoholic solution of propolis was obtained in the laboratory during 
3 days, temperature of +4 degrees with agitation.  
The composition of propolis varies from hive to hive, from district to district, and 
from season to season. Normally it is dark brown in color, but it can be found in green, red, 
black and white hues, depending on the sources of resin found in the particular hive area. 
Propolis consists of 55% resinous compounds and balsams, 30% beeswax, 10% 
aromatic oils, 5% bee pollen. Chemically, propolis is exceedingly complex and contains a rich 
variety of potent terpenes and benzoic, caffeic, cinnamic, and phenolic acids. Propolis is very 
high in flavanoid content, which has been proven to account for many of the health giving 
benefits attributed to propolis. 
Experimental groups of chicks were vaccinated with different vaccines and the 
vaccination occurred using different methods. Groups were formed with 25 chickens each, 
which had aged a day, the cross “Hi Land” and were kept in conditions analogous 
to maintain and feed.  
Three regular chickens were sacrificed of each examination. 
Chickens of group I served as the control group. 
Chicks in group II were vaccinated once with strain Ma5 + Clon30. 
Chickens in group III were vaccinated once the strain Ma5 + Clon30 in combination 
with the 10% hydro- alcoholic solution of propolis. 
  
REZULTS AND DISCUSSIONS 
 
The investigations were conducted on chickens from flocks vaccinated against 
infectious bronchitis avian parenting. Table 1 presents the results of serological 
investigations. The chickens of the I-st group served as controls.  
The chickens from II-nd experimental group were vaccinated with the vaccine against 
avian infectious bronchitis strain Ma5+Clon30 at the three day age. The vaccine was 
administered by "spray" method. 
The chickens from III-rd experimental group were vaccinated at the five days age 
with the same vaccine, lyophilized live vaccine combined against avian infectious 
bronchitis and avian Newcastle disease, strain Ma5+Clon30 (Nobilis). The vaccine is 
produced from attenuated virus strain (Ma5) avian infectious bronchitis and strain (Clon30) 
avian Newcastle disease. Vaccine was administered by „spray" method too. For these 
chickens from III-rd experimental group the vaccine was administered in combination 
with the 10% hydro- alcoholic solution of propolis.  
The 10% hydro- alcoholic solution of propolis was administered with drinking water 
in relation 10ml/1L water. This solution was administered five days before vaccination and 
five days after vaccination.  
At 10, 20, 30 and 40 days after vaccination in each group three headed chicken 
from which blood serum was collected for serological examination were each sacrificed. The 
body weight was examined each chicken. The blood serum was collected and was preserved 
by freezing in special tubes. The blood serum was used for   setting the 
level of antibody post vaccination titers against avian infectious bronchitis virus. 
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Table 1.  
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At the chickens of the group controls titer antibody were detected in the first life days 
and until 10 days old, but after that the titer antibody decreased at the other 
examinations conducted, because the chickens were obtained from vaccinated hens eggs and  
after 10 days the titer antibody decreased. The maternal antibodies were present until 10 
days age and then the titer antibody decreased because these chickens were not vaccinated. 
At the chickens of this group the highest post vaccination antibody titers were 1037.30 at 10 
days age and the lowest post vaccination antibody titers represented 845.14.   
In the first experimental group, where chickens were vaccinated only with strain 
Ma5+Clon30, at 10-th day after vaccination the antibody titers were the highest level 528.458. 
At the age of 20 days the level of antibody titers represented 150.007. We can observe that at 
age 10 days were detected reduce post-vaccination titer antibody which was not detected at 
the other examinations conducted. 
 On the 30-th day after vaccination the level of antibody titers then increases, while the 
chickens of II-nd experimental group where the chickens was vaccinated with strain 
Ma5+Clon30 in combination with 10% hydro- alcoholic solution of  propolis, show 
a considerable increase in the level of antibody titers being  2108.51. 
On the 40th day, at the highest level of antibody was specific for the II-nd 
experimental group which represented 2011.86. 
The results of these investigations demonstrated a high sensitivity ELISA test used for 
assessing the immunological efficacy of vaccines against avian infectious bronchitis and 




• The lyophilized live vaccine combined against avian infectious bronchitis and avian 
Newcastle disease, strain Ma5+Clon30 demonstrated a moderate immunological post 
vaccination effect. 
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• The vaccine strain Ma5+Clon30 administrated by spray method in combination with 
10% hydro- alcoholic solution of propolis which was administrated with   drinking water  
demonstrated  positive influence in raising of antibodies titer level. 
• The 10% hydro- alcoholic solution of propolis is a product which can be used 
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